文章摘要

艾滋病合并细菌性肺炎患者实施临床路径系统干预的效果

作者: 1周志慧, 2陈菊娣, 1陈仁芳, 1任勇
1 无锡市第五人民医院感染科，江苏 无锡 214000
2 无锡市第五人民医院护理部，江苏 无锡 214000
通讯: 陈菊娣 Email: 1239149866@qq.com
DOI: 10.3978/j.issn.2095-6959.2022.08.005
基金: 无锡市卫建委科研项目(MS201960)；中国公共卫生联盟护理研究项目(GWLM202036)。

摘要

目的：探讨艾滋病合并细菌性肺炎患者实施临床路径系统干预的效果。方法：选择2020年5月至2021年12月无锡市第五人民医院收治的艾滋病合并细菌性肺炎患者110例，随机分为两组，各55例。对照组实施常规干预，观察组实施临床路径系统干预。对比两组住院时间、住院花费、干预前后日常生活能力、心理状态及自我管理能力。结果：观察组干预后日常生活能力为3级者占50.91%，高于对照组；4级占49.09%，低于对照组。观察组住院时间为(19.72±5.19) d，短于对照组；住院花费为(16 628.49±5 901.37)元，低于对照组。观察组干预后躯体化、人际关系敏感、强迫、焦虑、抑郁、敌对、偏执、恐怖及精神病性评分分别为1.26±0.25、1.31±0.37、1.24±0.45、1.28±0.40、1.36±0.42、1.30±0.44、1.31±0.51、1.35±0.46及1.45±0.38，均低于对照组。观察组干预后症状管理、疾病认知、情绪管理、用药依从性、生活行为方式、获得社会支持及自我管理能力总分分别为21.19±3.07、22.53±2.41、20.38±3.61、21.02±2.96、22.01±2.83、20.96±3.15及127.82±11.39，均高于对照组(均P<0.05)。结论：艾滋病合并细菌性肺炎患者实施临床路径系统干预可提高其日常生活能力，改善心理状态及自我管理能力，缩短住院时间，降低住院花费。
关键词： 艾滋病；细菌性肺炎；临床路径系统干预；日常生活能力；心理状态；自我管理能力

Effect of clinical pathway systemic intervention in patients with AIDS complicated with pneumocystis pneumonia

Authors: 1ZHOU Zhihui, 2CHEN Judi, 1CHEN Renfang, 1REN Yong
1 Department of Infectious Diseases, Wuxi Fifth People’s Hospital, Wuxi Jiangsu 214000, China
2 Department of Nursing, Wuxi Fifth People’s Hospital, Wuxi Jiangsu 214000, China

CorrespondingAuthor: CHEN Judi Email: 1239149866@qq.com

DOI: 10.3978/j.issn.2095-6959.2022.08.005

Foundation: This work was supported by Wuxi Municipal Health and Construction Commission Scientific Research Project (MS201960), and Nursing Research Project of China Public Health Alliance (GWLM202036), China.

Abstract

Objective: To investigate the effect of systemic intervention of clinical pathways in patients with AIDS complicated with pneumocystis pneumonia. Methods: A total of 110 AIDS patients with pneumocystis pneumonia admitted to Wuxi Fifth People’s Hospital from May 2020 to December 2021 were selected and randomly divided into 2 groups, with 55 cases in each group. The control group was given routine intervention, and the observation group was given systemic intervention of clinical pathway. The hospitalization time, hospitalization expenditure, and daily living ability, mental state, and self-management ability before and after the intervention were compared between the 2 groups. Results: After the intervention, 50.91% of the observation group had the daily living ability of grade 3, which was higher than that of the control group, and the proportion of grade 4 was 49.09%, which was lower than that of the control group; the hospital stay in the observation group was (19.72±5.19) d, which was shorter than that of the control group. The hospitalization cost of the observation group was (16 628.49±5 901.37) yuan, which was lower than that of the control group; the scores of somatization, interpersonal sensitivity, compulsion, anxiety, depression, hostility, paranoia, terror and psychosis in the observation group were 1.26±0.25, 1.31±0.37, 1.24±0.45, 1.28±0.40, 1.36±0.42, 1.30±0.44, 1.31±0.51, 1.35±0.46 and 1.45±0.38, which were lower than those of the control group. The total scores of symptom management, disease cognition, emotional management, medication compliance, lifestyle and behavior, obtaining social support and self-management ability in the observation group after intervention were 21.19±3.07, 22.53±2.41, 20.38±3.61, 21.02±2.96, 22.01±2.83, 20.96±3.15 and 127.82±11.39, all higher than those in the control group (all P<0.05). Conclusion: The implementation of clinical pathway systemic intervention in patients with AIDS complicated with pneumocystis pneumonia can improve their daily life ability, improve their mental state and self-management ability, shorten the length of hospitalization, and reduce the cost of hospitalization.

Keywords： AIDS; pneumocystis pneumonia; clinical pathway system intervention; daily living ability; mental state; self-management ability

文章选项

下载引文

分享